May 21, 2018 / 4:03 PM / 5 months ago

BRIEF-GlaxoSmithKline Receives US Approval Of Arnuity Ellipta For Use In Children From 5 Years Old Who Suffer From Asthma

May 21 (Reuters) - GlaxoSmithKline PLC:

* GSK RECEIVES US APPROVAL OF ARNUITY ELLIPTA FOR USE IN CHILDREN FROM 5 YEARS OLD WHO SUFFER FROM ASTHMA

* RECEIVED APPROVAL FROM US FDA FOR USE OF ARNUITY ELLIPTA (FLUTICASONE FUROATE) FOR MAINTENANCE TREATMENT OF ASTHMA IN CHILDREN FROM AS YOUNG AS 5 YEARS Source: bit.ly/2KIfvII Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below